StockData

Chemed Corp (CHE) stock

CHENYSEServices-Home Health Care ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 17/306% above fair value
$546.75−2.70 (-0.49%)

Close on Nov 17, 2026Market cap $7.12BP/E 26.1Yield 0.40%

Chemed price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Chemed's price to sales ratio was 2.9× on Nov 11, 2026, against 2.6× a year earlier. Over the last 5 years it ranged from 2.2× to 4.3×, with a median of 3.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.9×+0.4
2025Dec 31, 20252.5×−0.9
2024Dec 31, 20243.4×−0.6
2023Dec 29, 20234.0×+0.3
2022Dec 30, 20223.6×−0.4
2021Dec 31, 20214.0×−0.2
2020Dec 31, 20204.2×+0.4
2019Dec 31, 20193.9×+1.2
2018Dec 31, 20182.7×+0.3
2017Dec 29, 20172.4×+0.7
2016Dec 30, 20161.7×+0.0
2015Dec 31, 20151.7×+0.4
2014Dec 31, 20141.3×+0.3
2013Dec 31, 20131.0×+0.1
2012Dec 31, 20120.9×+0.1
2011Dec 30, 20110.8×−0.3
2010Dec 31, 20101.2×+0.2
2009Dec 31, 20091.0×–

More Chemed figures

See a number that looks wrong?